Biliary tract cancer articles within Scientific Reports

Featured

• Article
  06 December 2023 | Open Access

  Development of a nomogram to predict survival in advanced biliary tract cancer

  • Hiroshi Imaoka
  • , Masafumi Ikeda
  •  & Makoto Ueno

• Article
  06 November 2023 | Open Access

  A novel model for predicting the prognosis of postoperative intrahepatic cholangiocarcinoma patients

  • Yinghao Lv
  • , Hu Liu
  •  & Hong Wu

• Article
  26 May 2023 | Open Access

  Patients' preferences in therapeutic decision-making in digestive oncology: a single centre cross-sectional observational study

  • Pierre Nizet
  • , Charlotte Grivel
  •  & Jean-François Huon

• Article
  13 February 2023 | Open Access

  Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study

  • Francesco Vasuri
  • , Marzia Deserti
  •  & Giovanni Brandi

• Article
  04 February 2022 | Open Access

  Prognostic value of Dickkopf-1 and ß-catenin expression according to the antitumor immunity of CD8-positive tumor-infiltrating lymphocytes in biliary tract cancer

  • Seo Ree Kim
  • , Hye Sung Won
  •  & Yoon Ho Ko

• Article
  18 June 2021 | Open Access

  Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113

  • Makoto Ueno
  • , Chigusa Morizane
  •  & Junji Furuse

• Article
  10 June 2021 | Open Access

  Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients

  • Eijiro Ueta
  • , Koichiro Tsutsumi
  •  & Hiroyuki Okada

• Article
  19 May 2021 | Open Access

  Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers

  • Nhu-An Pham
  • , Nikolina Radulovich
  •  & Ming-Sound Tsao

• Article
  26 April 2021 | Open Access

  The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro

  • Olivia Jones
  • , Xiaoqian Cheng
  •  & Jerome Canady

• Article
  23 February 2021 | Open Access

  Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway

  • Chenhao Tong
  • , Yali Wang
  •  & Baochun Lu

• Article
  28 October 2020 | Open Access

  Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9

  • Hera Saqub
  • , Hannah Proetsch-Gugerbauer
  •  & Altaf A. Dar

• Article
  25 September 2020 | Open Access

  Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological features

  • Kyoungbun Lee
  • , Young Seok Song
  •  & Gyeong Hoon Kang

• Article
  02 July 2020 | Open Access

  Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma

  • Chih-Yang Hsiao
  • , Po-Chih Yang
  •  & Kai-Wen Huang

• Article
  05 March 2020 | Open Access

  Analysis of risk factors associated with acute pancreatitis after endoscopic papillectomy

  • Eloy Taglieri
  • , Otávio Micelli-Neto
  •  & José Celso Ardengh

• Article
  21 November 2019 | Open Access

  Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway

  • Somsiri Indramanee
  • , Kanlayanee Sawanyawisuth
  •  & Sopit Wongkham

• Article
  13 September 2019 | Open Access

  Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information

  • T. J. Ettrich
  • , D. Schwerdel
  •  & A. W. Berger

• Article
  13 August 2019 | Open Access

  Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma

  • Tae Hyun Kim
  • , Sang Myung Woo
  •  & Dae Yong Kim

• Article
  11 April 2019 | Open Access

  Rituximab Decreases Lymphoproliferative Tumor Formation in Hepatopancreaticobiliary and Gastrointestinal Cancer Patient-Derived Xenografts

  • Jennifer L. Leiting
  • , Matthew C. Hernandez
  •  & Mark J. Truty

• Article
  03 April 2019 | Open Access

  Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis

  • Florian Moik
  • , Jakob M. Riedl
  •  & Florian Posch

• Article
  25 March 2019 | Open Access

  Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancer

  • Jung Ho Im
  • , Joon Seong Park
  •  & Ik Jae Lee

• Article
  13 March 2019 | Open Access

  Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma

  • Benjamin Goeppert
  • , Marcus Renner
  •  & Nalân Utku

• Article
  19 November 2018 | Open Access

  The efficacy of serum cell death biomarkers for diagnosing biliary tract cancer

  • Mitsuru Sugimoto
  • , Kazumichi Abe
  •  & Hiromasa Ohira

• Article
  17 July 2018 | Open Access

  Dual-organ invasion is associated with a lower survival rate than single-organ invasion in distal bile duct cancer: A multicenter study

  • Kyueng-Whan Min
  • , Dong-Hoon Kim
  •  & Ho Soon Choi

• Article
  04 April 2018 | Open Access

  Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer

  • Zhiwei Liu
  • , Troy J. Kemp
  •  & Jill Koshiol

• Article
  05 December 2017 | Open Access

  CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma

  • Sven H. Loosen
  • , Christoph Roderburg
  •  & Tom Luedde

• Article
  07 September 2017 | Open Access

  CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway

  • Dawoon E. Jung
  • , Soo Been Park
  •  & Si Young Song

• Article
  23 August 2017 | Open Access

  The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer

  • Mitsuru Sugimoto
  • , Tadayuki Takagi
  •  & Hiromasa Ohira

• Article
  13 July 2017 | Open Access

  The influence of marital status on survival of gallbladder cancer patients: a population-based study

  • Xinxing Li
  • , Ye Liu
  •  & Zhiqian Hu

• Article
  26 June 2017 | Open Access

  A Microfluidic Chip for Detecting Cholangiocarcinoma Cells in Human Bile

  • Lien-Yu Hung
  • , Nai-Jung Chiang
  •  & Gwo-Bin Lee

• Article
  03 October 2016 | Open Access

  Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis

  • De-Wen Tan
  • , Yan Fu
  •  & He-Ling Wang

• Article
  10 June 2016 | Open Access

  Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer

  • Wei Lu
  • , Yang Cao
  •  & Yingbin Liu

• Article
  03 May 2016 | Open Access

  Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer

  • Nai-Jung Chiang
  • , Chiun Hsu
  •  & Li-Tzong Chen

• Article
  11 April 2016 | Open Access

  The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy

  • Luca Faloppi
  • , Michela Del Prete
  •  & Mario Scartozzi

• Article
  08 January 2016 | Open Access

  High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation

  • Charupong Saengboonmee
  • , Wunchana Seubwai
  •  & Sopit Wongkham

• Article
  15 December 2015 | Open Access

  Variants and haplotypes in Flap endonuclease 1 and risk of gallbladder cancer and gallstones: a population-based study in China

  • Xingyuan Jiao
  • , Ying Wu
  •  & Wang Jun

• Article
  10 July 2015 | Open Access

  Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer

  • Daniel H. Ahn
  • , Junan Li
  •  & Tanios Bekaii-Saab